Keyphrases
Acute Coronary Syndrome
100%
Clopidogrel
100%
Thrombotic Risk
100%
Prasugrel
100%
High Thrombotic Risk
100%
Confidence Interval
50%
Adjusted Hazard Ratio
37%
Adverse Cardiac Events
37%
Prognostic Impact
37%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
37%
Risk-adjusted
25%
Low-to-moderate
25%
Risk Factors
12%
High-risk Features
12%
Myocardial Infarction
12%
Clinical Data
12%
Multivariable Cox Regression
12%
Multicenter Prospective Study
12%
Risk Reduction
12%
Revascularization
12%
Increased Incidence
12%
Coronary Intervention
12%
Ischemic Events
12%
Moderate Risk
12%
Antithrombotic Strategies
12%
Comorbid Factors
12%
Single Component
12%
Risk Definition
12%
Risk Criteria
12%
Risk Method
12%
Procedural Risk
12%
Propensity Score Stratification
12%
ESC Guidelines
12%
Medicine and Dentistry
Clopidogrel
100%
Prasugrel
100%
Acute Coronary Syndrome
100%
Hazard Ratio
75%
Major Adverse Cardiac Event
75%
ST Elevation
75%
Prevalence
50%
Percutaneous Coronary Intervention
50%
Apoplexy
25%
Myocardial Infarction
25%
Proportional Hazards Model
25%
Prospective Study
25%
Revascularization
25%
Antithrombotic
25%
Identified Patient
25%
Lanoteplase
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Clopidogrel
100%
Prasugrel
100%
Major Adverse Cardiac Event
75%
Prevalence
50%
Heart Infarction
25%
Anticoagulant Agent
25%
Prospective Study
25%
Cerebrovascular Accident
25%
Lanoteplase
25%
Comorbidity
25%
Biochemistry, Genetics and Molecular Biology
Clopidogrel
100%
Prasugrel
100%
ST Elevation
75%
Prevalence
50%
Prospective Study
25%
Comorbidity
25%